219 related articles for article (PubMed ID: 33518189)
21. Diagnostic Challenges in Ovarian Hyperthecosis: Clinical Presentation with Subdiagnostic Testosterone Levels.
Shah S; Torres C; Gharaibeh N
Case Rep Endocrinol; 2022; 2022():9998807. PubMed ID: 35087692
[TBL] [Abstract][Full Text] [Related]
22. Hyperandrogenism in a postmenopausal woman: diagnostic and therapeutic challenges.
Cheng V; Doshi KB; Falcone T; Faiman C
Endocr Pract; 2011; 17(2):e21-5. PubMed ID: 21247854
[TBL] [Abstract][Full Text] [Related]
23. Rare case of testosterone producing serous cystadenoma.
Khalid A; Kotha M; Munir AA
Oxf Med Case Reports; 2022 Aug; 2022(8):omac087. PubMed ID: 35991491
[TBL] [Abstract][Full Text] [Related]
24. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
[TBL] [Abstract][Full Text] [Related]
25. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.
Waggoner W; Boots LR; Azziz R
Gynecol Endocrinol; 1999 Dec; 13(6):394-400. PubMed ID: 10685333
[TBL] [Abstract][Full Text] [Related]
26. [The ovarian origin of hiperandrogenism in the postmenopausal woman the adrenal adenoma--a case report].
Mrozińska S; Kiałka M; Doroszewska K; Milewicz T; Jach R
Przegl Lek; 2015; 72(7):387-90. PubMed ID: 26817354
[TBL] [Abstract][Full Text] [Related]
27. The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report.
Suturina LV; Sharifulin EM; Sharifulin MA; Lazareva LM; Danusevich IN; Ievleva KD; Nadeliaeva IG
Metabolites; 2022 Jul; 12(7):. PubMed ID: 35888744
[TBL] [Abstract][Full Text] [Related]
28. A rare case of pure testosterone-secreting adrenal adenoma in a postmenopausal elderly woman.
Zhou WB; Chen N; Li CJ
BMC Endocr Disord; 2019 Jan; 19(1):14. PubMed ID: 30674304
[TBL] [Abstract][Full Text] [Related]
29. Dexamethasone suppression test versus selective ovarian and adrenal vein catheterization in identifying virilizing tumors in postmenopausal hyperandrogenism - a systematic review and meta-analysis.
Tng EL; Tan JM
Gynecol Endocrinol; 2021 Jul; 37(7):600-608. PubMed ID: 33660585
[TBL] [Abstract][Full Text] [Related]
30. How should postmenopausal androgen excess be evaluated?
Rothman MS; Wierman ME
Clin Endocrinol (Oxf); 2011 Aug; 75(2):160-4. PubMed ID: 21521309
[TBL] [Abstract][Full Text] [Related]
31. [Virilization and metabolic disease in postmenopausal women related to ovarian hyperplasia and hypertecosis].
Larrea AL; González VR; Knoblovits P; Gil SJ
Rev Fac Cien Med Univ Nac Cordoba; 2021 Jun; 78(2):193-196. PubMed ID: 34181829
[TBL] [Abstract][Full Text] [Related]
32. Postmenopausal onset of androgen excess: a diagnostic and therapeutic algorithm based on extensive clinical experience.
Luque-Ramírez M; Nattero-Chávez L; Rodríguez-Rubio Corona C; Ortiz-Flores AE; García-Cano AM; Rosillo Coronado M; Pérez Mies B; Ruz Caracuel I; Escobar-Morreale HF
J Endocrinol Invest; 2024 Feb; ():. PubMed ID: 38349517
[TBL] [Abstract][Full Text] [Related]
33. New onset alopecia and hirsutism in a postmenopausal women.
Bühler-Christen A; Tischler V; Diener PA; Brändle M
Gynecol Endocrinol; 2009 May; 25(5):324-7. PubMed ID: 19903039
[TBL] [Abstract][Full Text] [Related]
34. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women.
Barnes RB; Rosenfield RL; Ehrmann DA; Cara JF; Cuttler L; Levitsky LL; Rosenthal IM
J Clin Endocrinol Metab; 1994 Nov; 79(5):1328-33. PubMed ID: 7962325
[TBL] [Abstract][Full Text] [Related]
35. A Rare Case of Hyperandrogenism Due to Fibrothecoma and Leydig Cell Tumor in a Postmenopausal Woman With Adrenal Adenoma: A Case Report and Literature Review.
Hussain A; Uy E; Marlowe S; Piercy J; Akbar A
Cureus; 2023 Aug; 15(8):e43180. PubMed ID: 37692722
[TBL] [Abstract][Full Text] [Related]
36. Impact of clinical, hormonal, radiological, and immunohistochemical studies on the diagnosis of postmenopausal hyperandrogenism.
Sarfati J; Bachelot A; Coussieu C; Meduri G; Touraine P;
Eur J Endocrinol; 2011 Nov; 165(5):779-88. PubMed ID: 21896622
[TBL] [Abstract][Full Text] [Related]
37. Postmenopausal hyperandrogenism caused by a benign cystic teratoma: a case report.
Wu DH; McMurtrie DG; Hirsch SD; Johnston CM
J Reprod Med; 2008 Feb; 53(2):141-4. PubMed ID: 18357809
[TBL] [Abstract][Full Text] [Related]
38. The case of the elusive androgen.
Cobin RH
Endocr Pract; 2002; 8(6):433-8. PubMed ID: 15260009
[TBL] [Abstract][Full Text] [Related]
39. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
Kaltsas GA; Mukherjee JJ; Kola B; Isidori AM; Hanson JA; Dacie JE; Reznek R; Monson JP; Grossman AB
Clin Endocrinol (Oxf); 2003 Jul; 59(1):34-43. PubMed ID: 12807501
[TBL] [Abstract][Full Text] [Related]
40. Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?
Corbould A
Diabetes Metab Res Rev; 2008 Oct; 24(7):520-32. PubMed ID: 18615851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
